{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:12:28Z","timestamp":1789474348756,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Progetti d'Ateneo 2016"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of the study was to investigate the presence of subclinical vascular damage in polymyalgia rheumatica (PMR). We enrolled PMR patients having major cardiovascular risk factors (MCVRF) and, as controls, patients with MCVRF. All underwent: color Doppler ultrasound to evaluate the common carotid intima-media thickness (IMT), the anterior\u2013posterior abdominal aortic diameter (APAD), and the prevalence of carotid artery stenosis; the cardio-ankle vascular index (CAVI) to measure arterial stiffness together with the ankle-brachial index (ABI) to investigate the presence of lower-extremity peripheral arterial disease. Finally, we measured the serum levels of adipocytokines implicated in vascular dysfunction. As a result, 48 PMR and 56 MCVRF patients were included. An increase of IMT (1.07\/0.8\u20131.2 vs 0.8\/0.8\u20131.05; p\u2009=\u20090.0001), CAVI (8.7\/7.8\u20139.3 vs 7.6\/6.9\u20137.8; p\u2009&lt;\u20090.0001) and APAD values (21.15\/18.1\u201325.6 vs 18\/16\u201322; p\u2009=\u20090.0013) was found in PMR patients with respect to controls. No differences were reported in the prevalence of carotid artery stenosis or ABI values between the two groups. A significant correlation between IMT and CAVI in PMR and MCVRF subjects (r<jats:sup>2<\/jats:sup>\u2009=\u20090.845 and r<jats:sup>2<\/jats:sup>\u2009=\u20090.556, respectively; p\u2009&lt;\u20090.01) was found. Leptin levels (pg\/mL; median\/25th\u201375th percentile) were higher in PMR than in MCVRF subjects (145.1\/67\u2013398.6 vs 59.5\/39.3\u2013194.3; p\u2009=\u20090.04). Serum levels of adiponectin (ng\/mL) were higher in PMR patients (15.9\/10.65\u201324.1 vs 6.1\/2.8\u201322.7; p\u2009=\u20090.01), while no difference in serum levels of resistin (ng\/mL) was found between PMR and MCVRF subjects (0.37\/0.16\u20130.66 vs 0.26\/0.14\u20131.24). Our study shows an increased subclinical vascular damage in PMR patients compared to those with MCVRF, paving the way for further studies aimed at planning primary cardiovascular prevention in this population.<\/jats:p>","DOI":"10.1038\/s41598-020-68215-8","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:06:38Z","timestamp":1594289198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-8962","authenticated-orcid":false,"given":"Rossana","family":"Scrivo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciciarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Rutigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sestili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Barbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Altobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Di Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sili Scavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1969-2097","authenticated-orcid":false,"given":"Francesca Romana","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-1797","authenticated-orcid":false,"given":"Luciano","family":"Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"68215_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kes243","volume":"52","author":"KP Liao","year":"2013","unstructured":"Liao, K. P. et al. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford) 52, 45\u201352 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"68215_CR2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","volume":"63","author":"A Bremander","year":"2011","unstructured":"Bremander, A. et al. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res. (Hoboken) 63, 550\u2013556 (2011).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"68215_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","volume":"75","author":"I Essers","year":"2016","unstructured":"Essers, I. et al. Ankylosing spondylitis and risk of ischaemic heart disease: A population-based cohort study. Ann. Rheum. Dis. 75, 203\u2013209 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"68215_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon, N. N. et al. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: A population-based study. Ann. Intern. Med. 163, 409\u2013416 (2015).","journal-title":"Ann. Intern. Med."},{"key":"68215_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acr.23094","volume":"69","author":"K Jafri","year":"2017","unstructured":"Jafri, K. et al. Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: A population-based study. Arthritis Care Res. (Hoboken) 69, 51\u201357 (2017).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"68215_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2047487313514895","volume":"22","author":"L Clarson","year":"2015","unstructured":"Clarson, L. et al. Increased cardiovascular mortality associated with gout: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 22, 335\u2013343 (2015).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"68215_CR7","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1517\/14740338.2015.1073259","volume":"14","author":"F Benvenuti","year":"2015","unstructured":"Benvenuti, F. et al. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: A literature review. Expert. Opin. Drug Saf. 14, 1373\u20131385 (2015).","journal-title":"Expert. Opin. Drug Saf."},{"key":"68215_CR8","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar4267","volume":"15","author":"A Nordin","year":"2013","unstructured":"Nordin, A. et al. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: A population-based case\u2013control study. Arthritis Res. Ther. 15, R87 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"68215_CR9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","volume":"390","author":"MA Gonz\u00e1lez-Gay","year":"2017","unstructured":"Gonz\u00e1lez-Gay, M. A. et al. Polymyalgia rheumatica. Lancet 390, 1700\u20131712 (2017).","journal-title":"Lancet"},{"key":"68215_CR10","doi-asserted-by":"crossref","first-page":"E495","DOI":"10.1503\/cmaj.140266","volume":"186","author":"AT Hancock","year":"2014","unstructured":"Hancock, A. T. et al. Risk of vascular events in patients with polymyalgia rheumatica. CMAJ 186, E495-501 (2014).","journal-title":"CMAJ"},{"key":"68215_CR11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta, J. A. et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: A meta-analysis of observational studies. Ann. Rheum. Dis. 71, 1524\u20131529 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"68215_CR12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.21311","volume":"53","author":"HM Kremers","year":"2005","unstructured":"Kremers, H. M. et al. Direct medical cost of polymyalgia rheumatica. Arthritis Rheum. 53, 578\u2013584 (2005).","journal-title":"Arthritis Rheum."},{"key":"68215_CR13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/acr.21712","volume":"64","author":"AT Hancock","year":"2012","unstructured":"Hancock, A. T. et al. Association between polymyalgia rheumatica and vascular disease: A systematic review. Arthritis Care Res. (Hoboken) 64, 1301\u20131305 (2012).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"68215_CR14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"PJ Touboul","year":"2012","unstructured":"Touboul, P. J. et al. Cerebrovasc Dis 34, 290\u2013296 (2012).","journal-title":"Cerebrovasc Dis"},{"key":"68215_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5551\/jat.13.101","volume":"13","author":"K Shirai","year":"2006","unstructured":"Shirai, K. et al. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J. Atheroscler. Thromb. 13, 101\u2013107 (2006).","journal-title":"J. Atheroscler. Thromb."},{"key":"68215_CR16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta, B. et al. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheum. 64, 943\u2013954 (2012).","journal-title":"Arthritis Rheum."},{"key":"68215_CR17","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia, G. et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart. J. 34, 2159\u20132219 (2013).","journal-title":"Eur. Heart. J."},{"issue":"Suppl 1","key":"68215_CR18","first-page":"S11","volume":"35","author":"American Diabetes Association","year":"2012","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 35(Suppl 1), S11-63 (2012).","journal-title":"Diabetes Care"},{"key":"68215_CR19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2014.06.1159","volume":"64","author":"SC Smith Jr","year":"2014","unstructured":"Smith, S. C. Jr. et al. 2013 ACC\/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol. J. Am. Coll. Cardiol. 64, 601\u2013612 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68215_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ndt\/gfm517","volume":"23","author":"G Eknoyan","year":"2008","unstructured":"Eknoyan, G. Adolphe Quetelet (1796\u20131874)\u2014the average man and indices of obesity. Nephrol. Dial. Transplant. 23, 47\u201351 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"68215_CR21","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1582-4934.2010.01141.x","volume":"14","author":"DM Ouwens","year":"2010","unstructured":"Ouwens, D. M. et al. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J. Cell Mol. Med. 14, 2223\u20132234 (2010).","journal-title":"J. Cell Mol. Med."},{"key":"68215_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2016.05.037","volume":"252","author":"MF Piepoli","year":"2016","unstructured":"Piepoli, M. F. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 252, 207\u2013274 (2016).","journal-title":"Atherosclerosis"},{"key":"68215_CR23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(97)09292-1","volume":"351","author":"ECST Collaborative Group","year":"1998","unstructured":"ECST Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351, 1379\u20131387 (1998).","journal-title":"Lancet"},{"key":"68215_CR24","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"R Erbel","year":"2014","unstructured":"Erbel, R. et al. ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur. Heart J. 35, 2873\u20132926 (2014).","journal-title":"Eur. Heart J."},{"key":"68215_CR25","first-page":"275","volume":"34","author":"C Lavado-P\u00e9rez","year":"2015","unstructured":"Lavado-P\u00e9rez, C. et al. (18)F-FDG PET\/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica. Rev. Esp. Med. Nucl. Imagen Mol. 34, 275\u2013281 (2015).","journal-title":"Rev. Esp. Med. Nucl. Imagen Mol."},{"key":"68215_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00296-016-3557-5","volume":"37","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert, P. et al. Polymyalgia rheumatica and risk of coronary artery disease: A systematic review and meta-analysis of observational studies. Rheumatol. Int. 37, 143\u2013149 (2017).","journal-title":"Rheumatol. Int."},{"key":"68215_CR27","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/1756-185X.13328","volume":"21","author":"D Kobayashi","year":"2018","unstructured":"Kobayashi, D. et al. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study. Int. J. Rheum. Dis. 21, 1314\u20131321 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"68215_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000317106","volume":"30","author":"S Okazaki","year":"2010","unstructured":"Okazaki, S. et al. Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients. Cerebrovasc. Dis. 30, 180\u2013187 (2010).","journal-title":"Cerebrovasc. Dis."},{"key":"68215_CR29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.2003.011692","volume":"63","author":"F Moosig","year":"2004","unstructured":"Moosig, F. et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: A quantitative PET study. Ann. Rheum. Dis. 63, 870\u2013873 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"68215_CR30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.STR.32.2.454","volume":"32","author":"NM van Popele","year":"2001","unstructured":"van Popele, N. M. et al. Association between arterial stiffness and atherosclerosis: The Rotterdam Study. Stroke 32, 454\u2013460 (2001).","journal-title":"Stroke"},{"key":"68215_CR31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.5551\/jat.28035","volume":"22","author":"L Gomez-Sanchez","year":"2015","unstructured":"Gomez-Sanchez, L. et al. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in Caucasian adults: MARK study. J. Atheroscler. Thromb. 22, 901\u2013911 (2015).","journal-title":"J. Atheroscler. Thromb."},{"key":"68215_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1291\/hypres.30.335","volume":"30","author":"T Okura","year":"2007","unstructured":"Okura, T. et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens. Res. 30, 335\u2013340 (2007).","journal-title":"Hypertens. Res."},{"key":"68215_CR33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-014-0167-y","volume":"14","author":"M\u00c1 G\u00f3mez-Marcos","year":"2015","unstructured":"G\u00f3mez-Marcos, M. \u00c1 et al. Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: A case series report. Cardiovasc. Diabetol. 14, 7 (2015).","journal-title":"Cardiovasc. Diabetol."},{"key":"68215_CR34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1253\/circj.72.598","volume":"72","author":"K Nakamura","year":"2008","unstructured":"Nakamura, K. et al. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ. J. 72, 598\u2013604 (2008).","journal-title":"Circ. J."},{"key":"68215_CR35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1253\/circj.72.304","volume":"72","author":"K Kadota","year":"2008","unstructured":"Kadota, K. et al. Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ. J. 72, 304\u2013308 (2008).","journal-title":"Circ. J."},{"key":"68215_CR36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","volume":"40","author":"SE Gabriel","year":"1997","unstructured":"Gabriel, S. E. et al. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis. Rheum. 40, 1873\u20131878 (1997).","journal-title":"Arthritis. Rheum."},{"key":"68215_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/art.22548","volume":"57","author":"H MaraditKremers","year":"2007","unstructured":"MaraditKremers, H. et al. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum. 57, 279\u2013286 (2007).","journal-title":"Arthritis Rheum."},{"key":"68215_CR38","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2011-200751","volume":"71","author":"G Schillaci","year":"2012","unstructured":"Schillaci, G. et al. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment. Ann. Rheum. Dis. 71, 1151\u20131156 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"68215_CR39","doi-asserted-by":"crossref","first-page":"343746","DOI":"10.1155\/2014\/343746","volume":"2014","author":"V Abella","year":"2014","unstructured":"Abella, V. et al. Adipokines, metabolic syndrome and rheumatic diseases. J. Immunol. Res. 2014, 343746 (2014).","journal-title":"J. Immunol. Res."},{"key":"68215_CR40","doi-asserted-by":"crossref","first-page":"808125","DOI":"10.1155\/2013\/808125","volume":"2013","author":"R Scrivo","year":"2013","unstructured":"Scrivo, R. et al. Rheumatic diseases and obesity: Adipocytokines as potential comorbidity biomarkers for cardiovascular diseases. Mediators Inflamm. 2013, 808125 (2013).","journal-title":"Mediators Inflamm."},{"key":"68215_CR41","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.27616","volume":"62","author":"KW Frommer","year":"2010","unstructured":"Frommer, K. W. et al. Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum. 62, 2886\u20132899 (2010).","journal-title":"Arthritis Rheum."},{"key":"68215_CR42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.2009.05364.x","volume":"1193","author":"MA Cimmino","year":"2010","unstructured":"Cimmino, M. A. et al. Changes in adiponectin and leptin concentrations during glucocorticoid treatment: A pilot study in patients with polymyalgia rheumatica. Ann. N Y Acad. Sci. 1193, 160\u2013163 (2010).","journal-title":"Ann. N Y Acad. Sci."},{"key":"68215_CR43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/03009741003631479","volume":"39","author":"F Kreiner","year":"2010","unstructured":"Kreiner, F. et al. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scand. J. Rheumatol. 39, 402\u2013408 (2010).","journal-title":"Scand. J. Rheumatol."},{"key":"68215_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/metabo6030028","volume":"6","author":"N Tanaka","year":"2016","unstructured":"Tanaka, N. et al. Serum resistin level and progression of atherosclerosis during glucocorticoid therapy for systemic autoimmune diseases. Metabolites 6, 3 (2016).","journal-title":"Metabolites"},{"key":"68215_CR45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cyto.2015.04.004","volume":"75","author":"J Hutcheson","year":"2015","unstructured":"Hutcheson, J. Adipokines influence the inflammatory balance in autoimmunity. Cytokine 75, 272\u2013279 (2015).","journal-title":"Cytokine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68215-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68215-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68215-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:11:26Z","timestamp":1670335886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68215-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68215-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11407"}}